Anterior Cervical Plate for MIS: Low-Profile & FDA-Cleared

Low‑Profile Design for MIS – Enhanced Stability and Anatomical Alignment Our anterior cervical plate features a 1.2 mm ultra‑low profile with a pre‑contoured lordotic shape (12°‑15°), designed to minimize esophageal and tracheal contact while maintaining robust fixation for ACDF procedures. The plate’s streamlined geometry reduces the dissection required during implantation and enables placement through minimally invasive retractors with a 6‑level extension for multilevel constructs. Biomechanical testing demonstrated a flexion‑extension construct stiffness of 320 N/mm—comparable to standard plates—while reducing soft tissue footprint by 24%. In a clinical series of 74 MIS‑treated patients, the plate achieved a 98.6% fusion rate at 12 months, with a transient dysphagia rate of 2.7% (vs. 7.2% for standard plates in comparable studies). The intuitive screw‑targeting instrument set reduces fluoroscopy shots by an average of 6 per case.

Quality and Safety – Comprehensive Testing and Global Regulatory Compliance At Changzhou Geasure, every anterior cervical plate undergoes a comprehensive 10‑step testing protocol: raw material verification (Ti‑6Al‑4V ELI per ASTM F136), in‑process dimensional inspection (CMM, tolerance ±0.02 mm), static bending (≥400 N), fatigue endurance (500,000 cycles at 150 N per ASTM F382), corrosion resistance (no pitting to 800 mV per ASTM F2129), biocompatibility per ISO 10993‑5 (non‑cytotoxic), and sterility validation per ISO 11135. All products are CE marked (Class IIb) and FDA 510(k) cleared, with ISO 13485, 14001, 50001, and 45001 certifications. Since 2020, 100% of production lots have passed final release on first inspection, with a post‑market complaint rate of 0.08% across 18,200 plates.